Evidence map›Paper›PMID 30361876›Full record

ArticleFolia microbiologica2019

Prevalence of human pathogens of the clade Nakaseomyces in a culture collection-the first report on Candida bracarensis in Poland.

Marianna Małek, Paulina Mrowiec, Karolina Klesiewicz, Iwona Skiba-Kurek, Adrian Szczepański, Joanna Białecka, Iwona Żak, Bożena Bogusz, Jolanta Kędzierska, Alicja Budak and 1 more

Abstract read
In one paragraph

Article in Folia microbiologica, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. An update on clinically relevant, rare, and emergingClinical microbiology reviews · 2025
    Review
  3. Article
  4. Article
  5. Overview on the Infections Related to RarePathogens (Basel, Switzerland) · 2022
    Review
  6. Article
  7. Pharmaceutics · 2021
    Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Marianna MałekDepartment of Pharmaceutical Microbiology, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9 St., 30-688, Kraków, Poland. marianna.tokarczyk@uj.edu.pl.ORCID http://orcid.org/0000-0001-8940-6514
Paulina MrowiecDepartment of Pharmaceutical Microbiology, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9 St., 30-688, Kraków, Poland. paulina.mrowiec@uj.edu.pl.
Karolina KlesiewiczDepartment of Pharmaceutical Microbiology, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9 St., 30-688, Kraków, Poland.
Iwona Skiba-KurekDepartment of Pharmaceutical Microbiology, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9 St., 30-688, Kraków, Poland.
Adrian SzczepańskiDepartment of Microbiology, University Hospital in Kraków, Kraków, Poland.
Joanna BiałeckaCentre for Microbiological Research and Autovaccines, Kraków, Poland.
Iwona ŻakDepartment of Microbiology, University Children's Hospital of Kraków, Kraków, Poland.
Bożena BoguszDepartment of Microbiology, Ludwik Rydygier Memorial Hospital in Kraków, Kraków, Poland.
Jolanta KędzierskaDepartment of Microbiology, University Hospital in Kraków, Kraków, Poland.
Alicja BudakDepartment of Pharmaceutical Microbiology, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9 St., 30-688, Kraków, Poland.
Elżbieta KarczewskaDepartment of Pharmaceutical Microbiology, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9 St., 30-688, Kraków, Poland.

Funding

Uniwersytet Jagielloński Collegium Medicum K/DSC/002884
6 · The paper itself

Abstract

Human pathogens belonging to the Nakaseomyces clade include Candida glabrata sensu stricto, Candida nivariensis and Candida bracarensis. Their highly similar phenotypic characteristics often lead to misidentification by conventional laboratory methods. Therefore, limited information on the true epidemiology of the Candida glabrata species complex is available. Due to life-threatening infections caused by these species, it is crucial to supplement this knowledge. The aim of the study was to estimate the prevalence of C. bracarensis and C. nivariensis in a culture collection of C. glabrata complex isolates. The study covered 353 isolates identified by biochemical methods as C. glabrata, collected from paediatric and adult patients hospitalised at four medical centres in Southern Poland. The multiplex PCR was used to identify the strains. Further species confirmation was performed via sequencing and matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS) analysis. One isolate was recognised as C. bracarensis (0.28%). To our knowledge, it is the first isolate in Poland. C. glabrata sensu stricto species has been confirmed for all the remaining isolates. No C. nivariensis was found. Our study has shown that the prevalence of C. nivariensis and C. bracarensis strains is infrequent. However, it should be emphasised that the incidence of these strains may differ locally and depend on environmental factors and the population.

Indexed as

AdultAnti-Bacterial AgentsBiological Specimen BanksCandidaCandida glabrataCandidiasisChild, PreschoolCulture MediaHospitalizationHumansMicrobial Sensitivity TestsMultiplex Polymerase Chain ReactionPolandPrevalenceSequence Analysis, DNASpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationAnti-Bacterial AgentsCulture Media

Identifiers

PMID30361876
PMCPMC6529382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.